Novel mechanism offers hope for improved tolerability and efficacy in patients facing resistance or long-term toxicity with existing TKIs.
Amber Clemmon, PharmD, BCOP, FHOPA
Advertisement
Articles by Amber Clemmon, PharmD, BCOP, FHOPA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Opinion: Pharmacists Are Critical to Ensure Safe, Ethical Integration of AI in Health Care
2
FDA Removes Black Boxed Warning From Hormone Therapies for Menopause
3
Major Review Finds No Link Between Maternal Tylenol and Autism Spectrum Disorder, ADHD
4
Advanced Wearable Accelerometer Shows Promise in Detecting Functional Capacity and Outcomes in Heart Failure Patients
5
